Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

United Therapeutics (UTHR) Gross Profit (2016 - 2026)

United Therapeutics' Gross Profit history spans 17 years, with the latest figure at $686.8 million for Q4 2025.

  • On a quarterly basis, Gross Profit rose 4.06% to $686.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.8 billion, a 8.98% increase, with the full-year FY2025 number at $2.8 billion, up 8.98% from a year prior.
  • Gross Profit hit $686.8 million in Q4 2025 for United Therapeutics, down from $698.6 million in the prior quarter.
  • Over the last five years, Gross Profit for UTHR hit a ceiling of $711.0 million in Q2 2025 and a floor of $356.1 million in Q1 2021.
  • Historically, Gross Profit has averaged $539.2 million across 5 years, with a median of $535.8 million in 2023.
  • Biggest five-year swings in Gross Profit: surged 33.04% in 2024 and later grew 4.06% in 2025.
  • Tracing UTHR's Gross Profit over 5 years: stood at $380.6 million in 2021, then increased by 13.69% to $432.7 million in 2022, then grew by 25.65% to $543.7 million in 2023, then grew by 21.39% to $660.0 million in 2024, then rose by 4.06% to $686.8 million in 2025.
  • Business Quant data shows Gross Profit for UTHR at $686.8 million in Q4 2025, $698.6 million in Q3 2025, and $711.0 million in Q2 2025.